While many stocks offer forward dividend yields above 5%, the true value lies in quality rather than sheer quantity. Numerous offerings in this range are exposed to dividend cuts or price erosion that outweighs cash payouts, making selective investing essential.
Consequently, a careful selection of high‑quality dividend payers can mitigate these risks. Among the many candidates, three stocks—Energy Transfer (NYSE: ET), Pfizer (NYSE: PFE), and United Parcel Service (NYSE: UPS)—emerge as attractive long‑term options.
Energy Transfer offers a high yield and an AI growth catalyst
Energy Transfer operates as a master limited partnership (MLP) that owns midstream energy infrastructure, including pipelines. As a pass‑through entity, it distributes the majority of its pretax earnings to shareholders via quarterly cash distributions. At present, the stock delivers a forward dividend yield of approximately 6.6%.
The partnership has historically raised its distribution by 2% to 4% per year. Future growth in payouts may accelerate, driven by its indirect exposure to the artificial intelligence (AI) megatrend.
Rising demand from AI data centers for reliable power is expanding the need for midstream energy infrastructure. Leveraging this trend, Energy Transfer aims for 3% to 5% annualized distribution growth. If the stock appreciates in line with distribution growth and maintains its above‑average yield, the pipeline MLP could generate solid total returns for long‑term investors.
“Yield trap” worries are overblown with Pfizer
Pfizer offers a forward dividend yield approaching 7%, and its share price trades at roughly 8.5 times forward earnings. While these figures may appear attractive, concerns about the company’s recent financial performance have led some analysts to view the valuation with caution.
Despite the recent decline in sentiment, Pfizer remains a potentially undervalued pharmaceutical firm. It is currently navigating reduced demand for COVID‑19 vaccines and treatments, and it will confront a significant patent cliff in 2028 when exclusivity on its blockbuster anticoagulant Eliquis expires.
The company projects a 4% sales increase for its remaining product lines in 2026, with analysts forecasting earnings of $2.94 per share. At the current dividend level of $1.72 per share, this implies a forward payout ratio near 59%. While not optimal, sustained dividend growth is plausible if Pfizer replaces waning COVID‑19 and Eliquis sales with new offerings. The stock may eventually re‑rate toward a low‑teens forward valuation.
United Parcel Service could keep stumping the skeptics
United Parcel Service (UPS) provides a forward dividend yield of roughly 5.7%. It has increased its dividend annually for 16 consecutive years, although recent growth has moderated. The company’s payout ratio remains elevated, raising the possibility of a future dividend reduction.
Nevertheless, recent rebounds in UPS’s share price suggest optimism. Although concerns such as Amazon’s entry into logistics exist, favorable trends—including rising freight rates—support a positive outlook for the sector.
Analysts currently expect flat earnings growth this year, but improved pricing conditions may drive stronger results beginning in 2027, with consensus estimates projecting earnings of $8.02 per share, up from $7.13. As profitability rises and dividend coverage—represented by $6.56 in annual dividends—improves, UPS could deliver steady cash returns and continue its recovery, offering an appealing long‑term investment despite short‑term volatility.
Investors should consider Energy Transfer’s attractive yield, steady payout growth, and exposure to the AI‑driven energy market as compelling reasons to include the stock in a long‑term dividend portfolio.
